Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Ominsky

Showing results (21-30 of 81) with videos related to

Pageof 9
Sort By:
Bone Reports|July 9, 2020
Effects of abaloparatide and teriparatide on bone resorption and bone formation in female miceHeike Arlt, Tara Mullarkey, Dorothy Hu, et al.
The Journal of Bone and Joint Surgery. American Volume|May 9, 2023
Dual Inhibition of the Wnt Inhibitors DKK1 and Sclerostin Promotes Fracture Healing and Increases the Density and Strength of Uninjured Bone: An Experimental Study in Nonhuman PrimatesMonica Florio, Paul J Kostenuik, Marina Stolina, et al.
Bone Reports|June 30, 2018
Decreased osteoprogenitor proliferation precedes attenuation of cancellous bone formation in ovariectomized rats treated with sclerostin antibodyRogely Waite Boyce, Danielle Brown, Melanie Felx, et al.
Bone|December 3, 2014
Rapidly growing Brtl/+ mouse model of osteogenesis imperfecta improves bone mass and strength with sclerostin antibody treatmentBenjamin P Sinder, Joseph D Salemi, Michael S Ominsky, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|July 28, 2012
Sclerostin antibody improves skeletal parameters in a Brtl/+ mouse model of osteogenesis imperfectaBenjamin P Sinder, Mary M Eddy, Michael S Ominsky, et al.
Frontiers in Genetics|August 27, 2021
Gender-Related Impact of Sclerostin Antibody on Bone in the Osteogenesis Imperfecta MouseMickaël Cardinal, Antoine Chretien, Thomas Roels, et al.
Bone|April 15, 2014
Infant cynomolgus monkeys exposed to denosumab in utero exhibit an osteoclast-poor osteopetrotic-like skeletal phenotype at birth and in the early postnatal periodRogely W Boyce, Aurore Varela, Luc Chouinard, et al.
AJR. American Journal of Roentgenology|January 1, 1986
Multifocal abnormalities of the gastrointestinal tract in AIDSS D Wall, S Ominsky, D F Altman, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|December 21, 2017
Abaloparatide, a novel PTH receptor agonist, increased bone mass and strength in ovariectomized cynomolgus monkeys by increasing bone formation without increasing bone resorptionN Doyle, A Varela, S Haile, et al.
The Journal of Biological Chemistry|June 19, 2010
Are osteoclasts needed for the bone anabolic response to parathyroid hormone? A study of intermittent parathyroid hormone with denosumab or alendronate in knock-in mice expressing humanized RANKLDominique D Pierroz, Nicolas Bonnet, Paul A Baldock, et al.
Pageof 9

Showing results (21-30 of 81) with videos related to

Sort By:
Pageof 9
Bone Reports|July 9, 2020
Effects of abaloparatide and teriparatide on bone resorption and bone formation in female miceHeike Arlt, Tara Mullarkey, Dorothy Hu, et al.
The Journal of Bone and Joint Surgery. American Volume|May 9, 2023
Dual Inhibition of the Wnt Inhibitors DKK1 and Sclerostin Promotes Fracture Healing and Increases the Density and Strength of Uninjured Bone: An Experimental Study in Nonhuman PrimatesMonica Florio, Paul J Kostenuik, Marina Stolina, et al.
Bone Reports|June 30, 2018
Decreased osteoprogenitor proliferation precedes attenuation of cancellous bone formation in ovariectomized rats treated with sclerostin antibodyRogely Waite Boyce, Danielle Brown, Melanie Felx, et al.
Bone|December 3, 2014
Rapidly growing Brtl/+ mouse model of osteogenesis imperfecta improves bone mass and strength with sclerostin antibody treatmentBenjamin P Sinder, Joseph D Salemi, Michael S Ominsky, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|July 28, 2012
Sclerostin antibody improves skeletal parameters in a Brtl/+ mouse model of osteogenesis imperfectaBenjamin P Sinder, Mary M Eddy, Michael S Ominsky, et al.
Frontiers in Genetics|August 27, 2021
Gender-Related Impact of Sclerostin Antibody on Bone in the Osteogenesis Imperfecta MouseMickaël Cardinal, Antoine Chretien, Thomas Roels, et al.
Bone|April 15, 2014
Infant cynomolgus monkeys exposed to denosumab in utero exhibit an osteoclast-poor osteopetrotic-like skeletal phenotype at birth and in the early postnatal periodRogely W Boyce, Aurore Varela, Luc Chouinard, et al.
AJR. American Journal of Roentgenology|January 1, 1986
Multifocal abnormalities of the gastrointestinal tract in AIDSS D Wall, S Ominsky, D F Altman, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|December 21, 2017
Abaloparatide, a novel PTH receptor agonist, increased bone mass and strength in ovariectomized cynomolgus monkeys by increasing bone formation without increasing bone resorptionN Doyle, A Varela, S Haile, et al.
The Journal of Biological Chemistry|June 19, 2010
Are osteoclasts needed for the bone anabolic response to parathyroid hormone? A study of intermittent parathyroid hormone with denosumab or alendronate in knock-in mice expressing humanized RANKLDominique D Pierroz, Nicolas Bonnet, Paul A Baldock, et al.
Pageof 9